Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Goebel

Showing results (231-240 of 239) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 239 results.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1992
Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhageH Ehrenreich, M Lange, K A Near, et al.
Journal of Neurology|July 1, 1989
Myelin basic protein in the cerebrospinal fluid of patients infected with HIVH W Pfister, K M Einhäupl, M Wick, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 24, 1998
Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virusK Hartmann, M Kuffer, J Balzarini, et al.
The New England Journal of Medicine|July 29, 1993
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative GroupD A Cooper, J M Gatell, S Kroon, et al.
Infection|November 1, 1995
Pharmacokinetics of orally administered zidovudine in HIV-infected children and adultsU Wintergerst, B Rolinski, M Vocks-Hauck, et al.
AIDS (London, England)|February 24, 2001
Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapyF D Goebel, R Hemmer, J C Schmit, et al.
AIDS (London, England)|August 28, 1999
Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study GroupF D Goebel, J W Mannhalter, R B Belshe, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupP Sudre, B J Hirschel, J M Gatell, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 24

Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1992
Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhageH Ehrenreich, M Lange, K A Near, et al.
Journal of Neurology|July 1, 1989
Myelin basic protein in the cerebrospinal fluid of patients infected with HIVH W Pfister, K M Einhäupl, M Wick, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 24, 1998
Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virusK Hartmann, M Kuffer, J Balzarini, et al.
The New England Journal of Medicine|July 29, 1993
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative GroupD A Cooper, J M Gatell, S Kroon, et al.
Infection|November 1, 1995
Pharmacokinetics of orally administered zidovudine in HIV-infected children and adultsU Wintergerst, B Rolinski, M Vocks-Hauck, et al.
AIDS (London, England)|February 24, 2001
Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapyF D Goebel, R Hemmer, J C Schmit, et al.
AIDS (London, England)|August 28, 1999
Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study GroupF D Goebel, J W Mannhalter, R B Belshe, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupP Sudre, B J Hirschel, J M Gatell, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 24